Stock Details
4578.T is Otsuka Holdings Co., Ltd.'s stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 4,395.06๏ฟฅ. Average daily volumn in 3 months 948.76k. Market cap 2.26T



Stock symbol : 4578.T. Exchange : Tokyo. Currency : JPY
Lastest price : 4,158.00๏ฟฅ. Total volume : 879.00k. Market state POSTPOST
Click reload if you want to check the lastest price on market!!!

Otsuka Holdings Co., Ltd. (4578.T)
Last Price
4,158.00๏ฟฅ
Change
-12.00
Volume
879.00k

Previous Close4,170.00
Open4,190.00
Day Range4,154.00-4,200.00
Bid4,156.00 x N/A
Ask4,161.00 x N/A
Volume879k
Average Volume948.76k
Market Cap2.26T
Beta0.29
52 Week Range3,831.00-5,000.00
Trailing P/E20.54
Foward P/E14.20
Dividend (Yield %)2.40%
Ex-Dividend Date2022-12-29



Financial Details


According to Otsuka Holdings Co., Ltd.'s financial reports the company's revenue in 2021 were 1.5T an increase(0%) over the years 2020 revenue that were of 1.42T. In 2021 the company's total earnings were 125.46B while total earnings in 2020 were 148.14B(-15.54%).


Loading ...



Organization

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides BODYMAINTร‰ Jelly, a conditioning food product; BODYMAINTร‰ Drink, a conditioning beverage; EQUELLE and EQUELLE Gelรฉe, wh... ich supports women's health and beauty; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; and OS-1, an oral rehydration solution. In addition, the company offers soft drinks, food products, and wines; clinical testing and medical equipment; cosmetics; warehousing and transport services; chemical products; travel agency services; analysis and measurement equipment; pharmaceutical intermediates; testing equipment, such as vehicle headlight testers; synthetic resin molded products; venture capital services; paper products; artificial turf; ceramic boards, ceramic board masterpiece arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; IT solution services; insecticides and toiletry products; and flaky titanate and special compounds. Further, it provides infusion and clinical nutrition products; Xenotransplantation products; hydrazine; plant-based food products, including cheese alternatives, dressings, and desserts; stable isotopes; software and services to enhance management of mental healthcare systems; products for urinary tract health; potassium titanate; bio-pesticides; functional and dietetic foods; spring and mineral water; industrial chemicals; polyolefin foams; anticancer drugs; and adhesive tapes. Additionally, the company operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

Market Cap:
2.26T
Revenue:
1.5T
Total Assets:
2.82T
Total Cash:
410.68B


News about "Otsuka Holdings Co., Ltd."

Otsuka Holdings Co. Ltd.

Source from : Wall Street Journal - 1 month ago

1 Day OTSKF -7.11% DJIA 0.33% S&P 500 0.40% Health Care/Life Sciences 0.23% Ichiro Otsuka Chairman Otsuka Pharmaceutical Factory, Inc., Otsuka Pharmaceutical Co., Ltd., Otsuka Holdings Co., Ltd ...See details»


Otsuka Holdings

Source from : Statista - 1 month ago

Otsuka Holdings was founded in 2008 and operates in Japan. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC: 2100). This industry belongs to the ...See details»


Otsuka Holdings Ltd (4578)

Source from : Investing - 1 month ago

Investing.com โ€“ Japan equities were higher at the close on Friday, as gains in the Rubber, Electrical/Machinery and Food sectors propelled shares higher. At the close in Tokyo,... Investing.com โ€“ ...See details»


ReCor Medical Names Lara Barghout President and Chief Executive Officer

Source from : Yahoo - 9 days ago

Executive Director of Otsuka Holdings Co., Ltd. and President of Otsuka Medical Devices. "We are very excited for Ms. Barghout to lead ReCor into its next phase of global growth. Her deep ...See details»


bipolar-disorder-treatment-market-will-achieve-usd-57-billion-by-2030-greyviews-image

Bipolar Disorder Treatment Market will achieve USD 5.7 billion by 2030 : GreyViews

Source from : YAHOO!Finance - 1 days ago

By Mechanism of Action (Beta-Blockers, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressant Drugs and Others), Regions, Segmentation, and forecast till 2030.Pune India, Jan. 30, 2023 ...See details»


With Astonishing CAGR, Multivitamin Supplements Market Generate Revenue at Significant Rate, 2029

Source from : MarketWatch - 13 days ago

Multivitamin Supplements Market 2022 Report (Report Pages-112) offers a Comprehensive assessment regarding the ...See details»


cns-treatment-and-therapy-market-is-predicted-to-be-valued-at-us-192-billion-by-2032-image

CNS Treatment and Therapy Market is predicted to be valued at US$ 192 Billion by 2032

Source from : Future Market Insights - 7 days ago

During the forecast period, theย CNS Treatment and Therapy Marketย Shareย is anticipated to expand at a moderate CAGR of 4.8%. As a result, it is predicted that the market for CNS treatments and ...See details»


Global Wellness Supplements Market 2022 to 2031 - Players Include Nestle, Shaklee, Otsuka Pharmaceutical and GNC Holdings

Source from : Yahoo Finance - 15 days ago

Suitable for supporting your internal and external presentations with reliable high quality data and analysis Major players in the wellness supplements market are Nestle, Shaklee Corporation, Otsuka ...See details»


Otsuka Holdings Co Ltd (OS1.SG)

Source from : Yahoo Finance - 5 days ago

As of 08:02AM CET. Market open. Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider ...See details»


ReCor Medical Names Lara Barghout President and Chief Executive Officer

Source from : Benzinga.com - 28 days ago

ReCor Medical, Inc. ("ReCor") and its parent company, Otsuka Medical Devices Co., Ltd. ("Otsuka Medical Devices") today announced the appointment of Lara Barghout as President and Chief Executive ...See details»


Otsuka Holdings Co. Ltd.

Source from : Wall Street Journal - 1 month ago

1 Day 4578 -0.65% DJIA -0.22% S&P 500 -0.25% Health Care/Life Sciences -0.42% Ichiro Otsuka Chairman Otsuka Pharmaceutical Factory, Inc., Otsuka Pharmaceutical Co., Ltd., Otsuka Holdings Co., Ltd ...See details»


OTSKY Otsuka Holdings Co., Ltd.

Source from : Seeking Alpha - 1 month ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»


ReCor Medical Names Lara Barghout President and Chief Executive Officer

Source from : Yahoo News New Zealand - 28 days ago

Ms. Barghout brings more than 20 years of experience leading global businesses in the medical device industry. She joins ReCor from Siemens Healthineers, where she was Senior Vice President and Head ...See details»


Otsuka Holdings Co Ltd ADR (OTSKY)

Source from : Investing - 18 days ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»